Resumen
The direct estimation of heritability from genome-wide common variant data as implemented in the program Genome-wide Complex Trait Analysis (GCTA) has provided a means to quantify heritability attributable to all interrogated variants. We have quantified the variance in liability to disease explained by all SNPs for two phenotypically-related neurobehavioral disorders, obsessive-compulsive disorder (OCD) and Tourette Syndrome (TS), using GCTA. Our analysis yielded a heritability point estimate of 0.58 (se = 0.09, p = 5.64e-12) for TS, and 0.37 (se = 0.07, p = 1.5e-07) for OCD. In addition, we conducted multiple genomic partitioning analyses to identify genomic elements that concentrate this heritability. We examined genomic architectures of TS and OCD by chromosome, MAF bin, and functional annotations. In addition, we assessed heritability for early onset and adult onset OCD. Among other notable results, we found that SNPs with a minor allele frequency of less than 5% accounted for 21% of the TS heritability and 0% of the OCD heritability. Additionally, we identified a significant contribution to TS and OCD heritability by variants significantly associated with gene expression in two regions of the brain (parietal cortex and cerebellum) for which we had available expression quantitative trait loci (eQTLs). Finally we analyzed the genetic correlation between TS and OCD, revealing a genetic correlation of 0.41 (se = 0.15, p = 0.002). These results are very close to previous heritability estimates for TS and OCD based on twin and family studies, suggesting that very little, if any, heritability is truly missing (i.e., unassayed) from TS and OCD GWAS studies of common variation. The results also indicate that there is some genetic overlap between these two phenotypically-related neuropsychiatric disorders, but suggest that the two disorders have distinct genetic architectures.
Idioma original | Inglés |
---|---|
Número de artículo | e1003864 |
Publicación | PLoS Genetics |
Volumen | 9 |
N.º | 10 |
DOI | |
Estado | Publicada - oct. 2013 |
Publicado de forma externa | Sí |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
Acceder al documento
Huella
Profundice en los temas de investigación de 'Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
En: PLoS Genetics, Vol. 9, N.º 10, e1003864, 10.2013.
Producción científica: Contribución a una revista › Artículo en revista científica indexada › revisión exhaustiva
TY - JOUR
T1 - Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture
AU - Davis, Lea K.
AU - Yu, Dongmei
AU - Keenan, Clare L.
AU - Gamazon, Eric R.
AU - Konkashbaev, Anuar I.
AU - Derks, Eske M.
AU - Neale, Benjamin M.
AU - Yang, Jian
AU - Lee, S. Hong
AU - Evans, Patrick
AU - Barr, Cathy L.
AU - Bellodi, Laura
AU - Benarroch, Fortu
AU - Berrio, Gabriel Bedoya
AU - Bienvenu, Oscar J.
AU - Bloch, Michael H.
AU - Blom, Rianne M.
AU - Bruun, Ruth D.
AU - Budman, Cathy L.
AU - Camarena, Beatriz
AU - Campbell, Desmond
AU - Cappi, Carolina
AU - Cardona Silgado, Julio C.
AU - Cath, Danielle C.
AU - Cavallini, Maria C.
AU - Chavira, Denise A.
AU - Chouinard, Sylvain
AU - Conti, David V.
AU - Cook, Edwin H.
AU - Coric, Vladimir
AU - Cullen, Bernadette A.
AU - Deforce, Dieter
AU - Delorme, Richard
AU - Dion, Yves
AU - Edlund, Christopher K.
AU - Egberts, Karin
AU - Falkai, Peter
AU - Fernandez, Thomas V.
AU - Gallagher, Patience J.
AU - Garrido, Helena
AU - Geller, Daniel
AU - Girard, Simon L.
AU - Grabe, Hans J.
AU - Grados, Marco A.
AU - Greenberg, Benjamin D.
AU - Gross-Tsur, Varda
AU - Haddad, Stephen
AU - Heiman, Gary A.
AU - Hemmings, Sian M.J.
AU - Hounie, Ana G.
AU - Illmann, Cornelia
AU - Jankovic, Joseph
AU - Jenike, Michael A.
AU - Kennedy, James L.
AU - King, Robert A.
AU - Kremeyer, Barbara
AU - Kurlan, Roger
AU - Lanzagorta, Nuria
AU - Leboyer, Marion
AU - Leckman, James F.
AU - Lennertz, Leonhard
AU - Liu, Chunyu
AU - Lochner, Christine
AU - Lowe, Thomas L.
AU - Macciardi, Fabio
AU - McCracken, James T.
AU - McGrath, Lauren M.
AU - Mesa Restrepo, Sandra C.
AU - Moessner, Rainald
AU - Morgan, Jubel
AU - Muller, Heike
AU - Murphy, Dennis L.
AU - Naarden, Allan L.
AU - Ochoa, William Cornejo
AU - Ophoff, Roel A.
AU - Osiecki, Lisa
AU - Pakstis, Andrew J.
AU - Pato, Michele T.
AU - Pato, Carlos N.
AU - Piacentini, John
AU - Pittenger, Christopher
AU - Pollak, Yehuda
AU - Rauch, Scott L.
AU - Renner, Tobias J.
AU - Reus, Victor I.
AU - Richter, Margaret A.
AU - Riddle, Mark A.
AU - Robertson, Mary M.
AU - Romero, Roxana
AU - Rosàrio, Maria C.
AU - Rosenberg, David
AU - Rouleau, Guy A.
AU - Ruhrmann, Stephan
AU - Ruiz-Linares, Andres
AU - Sampaio, Aline S.
AU - Samuels, Jack
AU - Sandor, Paul
AU - Sheppard, Brooke
AU - Singer, Harvey S.
AU - Smit, Jan H.
AU - Stein, Dan J.
AU - Strengman, E.
AU - Tischfield, Jay A.
AU - Valencia Duarte, Ana V.
AU - Vallada, Homero
AU - Van Nieuwerburgh, Filip
AU - Veenstra-VanderWeele, Jeremy
AU - Walitza, Susanne
AU - Wang, Ying
AU - Wendland, Jens R.
AU - Westenberg, Herman G.M.
AU - Shugart, Yin Yao
AU - Miguel, Euripedes C.
AU - McMahon, William
AU - Wagner, Michael
AU - Nicolini, Humberto
AU - Posthuma, Danielle
AU - Hanna, Gregory L.
AU - Heutink, Peter
AU - Denys, Damiaan
AU - Arnold, Paul D.
AU - Oostra, Ben A.
AU - Nestadt, Gerald
AU - Freimer, Nelson B.
AU - Pauls, David L.
AU - Wray, Naomi R.
AU - Stewart, S. Evelyn
AU - Mathews, Carol A.
AU - Knowles, James A.
AU - Cox, Nancy J.
AU - Scharf, Jeremiah M.
N1 - Funding Information: The following authors have read the journal's policy and have the following conflicts: CLBu: Currently receiving funding for TS clinical trials from Otsuka Pharmaceutical, JFL: recevies research support from NIH and Grifols, LLC as well royalties from John Wiley and Sons, McGraw Hill, and Oxford University Press, MARic: received honoraria from Lundbeck, and research funding from Great-West Life Assurance Company of Canada and Eli Lilly Canada Ltd, MCR: grant from CNPq (Brazilian National Counsil) and has received research grants and/or consultancy honoraria from Novartis and Shire, DR: received consulting fees for Shire, JMS: received research support, honoraria and travel support from the Tourette Syndrome Association (TSA), DJS: received research grants and/or consultancy honoraria from Abbott, Astrazeneca, Biocodex, Eli-Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Takeda, Tikvah, and Wyeth, TVF: received research funding from NIMH (K08 MH099424-01), the Simons Foundation, Allison Foundation, and Shire, PS: received research support for this study from the Tourette Syndrome Association (TSA), Tourette Syndrome Foundation of Canada and NIH, DY: received research support from the Tourette Syndrome Association (TSA) and NIH, MMR: received grants from the Tourette's Action-UK, TSA-USA, honoraria from Janssen-Cilag, and book royalties from Wiley - Blackwell, David Fulton/Granada/Taylor Francis, Oxford University Press and Jessica Kingsley Publishers, is a Patron of Tourette's Action (UK), sits on the Medical Advisory Board of the Italian Tourette Syndrome Association and The Tourette Syndrome Foundation of Canada, DAC: NIH/NIMH funding for K01 MH072952 and R34 MH090149, SLR: participated in research funded by Medtronic and Cyberonics, JRW: Past employee of F. Hoffmann-La Roche and current employee of Pfizer, SW: received lecture honoraria from Janssen Cilag, AstraZeneca and Eli Lilly, research funds Swiss National Science Foundation (SNF), Deutsche Forschungsgemeinschaft, EU FP7, HSM Hochspezialisierte Medizin of the Kanton Zurich, Switzerland, JV: funding from Seaside Therapeutics, Novartis, Roche Pharmaceuticals, Forest, and SynapDx. Consulting/Advisory Board for Novartis, JTM: Tourette Syndrome Association-Speaker honoraria; Otuska-research grant; Roche-consultant; 1R01MH079487-01A1, JLK: honoraria from Roche, Eli Lilly, and Novartis, PDA: Unrestricted research grant from DNA Genotek SLG, HJG, ML, DLP, SES, NL, JHS, CLBa, LB, FB, GBB, OJB, MHB, RMB, RDB, DC, CC, JCCS, DCC, MCC, SC, DVC, EHC, VC, NJC, BAC, LKD, DDen, DDef, RD, EMD, YD, CKE, KE, PF, NBF, PJG, ERG, HG, MAG, BDG, VGT, SH, GLH, GAH, SMJH, PH, AGH, CI, JJ, MAJ, CLK, RAK, JAK, AIK, BK, RK, SHL, LL, CLi, CLo, TLL, FM, CAM, LMM, WM, SCMR, ECM, RM, JM, HM, DLM, ALN, BMN, GN, HN, WCO, BAO, RAO, LO, AJP, MTP, CNP, CP, YP, DP, TJR, VIR, MARid, GAR, SR, ARL, ASS, JS, BS, HSS, ES, JAT, AVVD, HV, MW, YW, JY, HGMW, PE, BC, RR have declared that no competing interests exist.
PY - 2013/10
Y1 - 2013/10
N2 - The direct estimation of heritability from genome-wide common variant data as implemented in the program Genome-wide Complex Trait Analysis (GCTA) has provided a means to quantify heritability attributable to all interrogated variants. We have quantified the variance in liability to disease explained by all SNPs for two phenotypically-related neurobehavioral disorders, obsessive-compulsive disorder (OCD) and Tourette Syndrome (TS), using GCTA. Our analysis yielded a heritability point estimate of 0.58 (se = 0.09, p = 5.64e-12) for TS, and 0.37 (se = 0.07, p = 1.5e-07) for OCD. In addition, we conducted multiple genomic partitioning analyses to identify genomic elements that concentrate this heritability. We examined genomic architectures of TS and OCD by chromosome, MAF bin, and functional annotations. In addition, we assessed heritability for early onset and adult onset OCD. Among other notable results, we found that SNPs with a minor allele frequency of less than 5% accounted for 21% of the TS heritability and 0% of the OCD heritability. Additionally, we identified a significant contribution to TS and OCD heritability by variants significantly associated with gene expression in two regions of the brain (parietal cortex and cerebellum) for which we had available expression quantitative trait loci (eQTLs). Finally we analyzed the genetic correlation between TS and OCD, revealing a genetic correlation of 0.41 (se = 0.15, p = 0.002). These results are very close to previous heritability estimates for TS and OCD based on twin and family studies, suggesting that very little, if any, heritability is truly missing (i.e., unassayed) from TS and OCD GWAS studies of common variation. The results also indicate that there is some genetic overlap between these two phenotypically-related neuropsychiatric disorders, but suggest that the two disorders have distinct genetic architectures.
AB - The direct estimation of heritability from genome-wide common variant data as implemented in the program Genome-wide Complex Trait Analysis (GCTA) has provided a means to quantify heritability attributable to all interrogated variants. We have quantified the variance in liability to disease explained by all SNPs for two phenotypically-related neurobehavioral disorders, obsessive-compulsive disorder (OCD) and Tourette Syndrome (TS), using GCTA. Our analysis yielded a heritability point estimate of 0.58 (se = 0.09, p = 5.64e-12) for TS, and 0.37 (se = 0.07, p = 1.5e-07) for OCD. In addition, we conducted multiple genomic partitioning analyses to identify genomic elements that concentrate this heritability. We examined genomic architectures of TS and OCD by chromosome, MAF bin, and functional annotations. In addition, we assessed heritability for early onset and adult onset OCD. Among other notable results, we found that SNPs with a minor allele frequency of less than 5% accounted for 21% of the TS heritability and 0% of the OCD heritability. Additionally, we identified a significant contribution to TS and OCD heritability by variants significantly associated with gene expression in two regions of the brain (parietal cortex and cerebellum) for which we had available expression quantitative trait loci (eQTLs). Finally we analyzed the genetic correlation between TS and OCD, revealing a genetic correlation of 0.41 (se = 0.15, p = 0.002). These results are very close to previous heritability estimates for TS and OCD based on twin and family studies, suggesting that very little, if any, heritability is truly missing (i.e., unassayed) from TS and OCD GWAS studies of common variation. The results also indicate that there is some genetic overlap between these two phenotypically-related neuropsychiatric disorders, but suggest that the two disorders have distinct genetic architectures.
UR - http://www.scopus.com/inward/record.url?scp=84887265151&partnerID=8YFLogxK
U2 - 10.1371/journal.pgen.1003864
DO - 10.1371/journal.pgen.1003864
M3 - Artículo en revista científica indexada
C2 - 24204291
AN - SCOPUS:84887265151
SN - 1553-7390
VL - 9
JO - PLoS Genetics
JF - PLoS Genetics
IS - 10
M1 - e1003864
ER -